Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Youssef Youssef

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Cell Reports|July 5, 2016
NKp80 Defines a Critical Step during Human Natural Killer Cell DevelopmentAharon G Freud, Karen A Keller, Steven D Scoville, et al.
International Journal of Radiation Oncology, Biology, Physics|June 14, 2002
Improving the consistency in cervical esophageal target volume definition by special trainingPatricia Tai, Jake Van Dyk, Jerry Battista, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 4, 2026
Clinical characteristics associated with terminal methotrexate clearance in patients with non-Hodgkin lymphomas receiving high-dose methotrexateZachary J Arnold, Jordan Lundberg, Tracy Wiczer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 6, 2020
Notch Regulates Innate Lymphoid Cell Plasticity during Human NK Cell DevelopmentAnsel P Nalin, Jesse J Kowalski, Alexander C Sprague, et al.
Blood Advances|July 29, 2018
Highly cytotoxic natural killer cells are associated with poor prognosis in patients with cutaneous T-cell lymphomaBethany Mundy-Bosse, Nathan Denlinger, Eric McLaughlin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2021
SOX11 Inhibitors Are Cytotoxic in Mantle Cell LymphomaShashidhar S Jatiani, Stephanie Christie, Violetta V Leshchenko, et al.
Blood Immunology & Cellular Therapy|July 8, 2026
Identification of an optimal absolute lymphocyte count at leukapheresis in patients with lymphoma treated with CARTKunhwa Kim, Zachary Hunzeker, Xiaowen Sun, et al.
Plos One|May 14, 2021
Validation of protein arginine methyltransferase 5 (PRMT5) as a candidate therapeutic target in the spontaneous canine model of non-Hodgkin lymphomaShelby L Sloan, Kyle A Renaldo, Mackenzie Long, et al.
Experimental Hematology & Oncology|July 13, 2022
A sumoylation program is essential for maintaining the mitotic fidelity in proliferating mantle cell lymphoma cellsWalter Hanel, Pushpa Lata, Youssef Youssef, et al.
Blood Advances|June 16, 2023
PRMT5 inhibition drives therapeutic vulnerability to combination treatment with BCL-2 inhibition in mantle cell lymphomaFiona Brown-Burke, Inah Hwang, Shelby Sloan, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Cell Reports|July 5, 2016
NKp80 Defines a Critical Step during Human Natural Killer Cell DevelopmentAharon G Freud, Karen A Keller, Steven D Scoville, et al.
International Journal of Radiation Oncology, Biology, Physics|June 14, 2002
Improving the consistency in cervical esophageal target volume definition by special trainingPatricia Tai, Jake Van Dyk, Jerry Battista, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 4, 2026
Clinical characteristics associated with terminal methotrexate clearance in patients with non-Hodgkin lymphomas receiving high-dose methotrexateZachary J Arnold, Jordan Lundberg, Tracy Wiczer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 6, 2020
Notch Regulates Innate Lymphoid Cell Plasticity during Human NK Cell DevelopmentAnsel P Nalin, Jesse J Kowalski, Alexander C Sprague, et al.
Blood Advances|July 29, 2018
Highly cytotoxic natural killer cells are associated with poor prognosis in patients with cutaneous T-cell lymphomaBethany Mundy-Bosse, Nathan Denlinger, Eric McLaughlin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2021
SOX11 Inhibitors Are Cytotoxic in Mantle Cell LymphomaShashidhar S Jatiani, Stephanie Christie, Violetta V Leshchenko, et al.
Blood Immunology & Cellular Therapy|July 8, 2026
Identification of an optimal absolute lymphocyte count at leukapheresis in patients with lymphoma treated with CARTKunhwa Kim, Zachary Hunzeker, Xiaowen Sun, et al.
Plos One|May 14, 2021
Validation of protein arginine methyltransferase 5 (PRMT5) as a candidate therapeutic target in the spontaneous canine model of non-Hodgkin lymphomaShelby L Sloan, Kyle A Renaldo, Mackenzie Long, et al.
Experimental Hematology & Oncology|July 13, 2022
A sumoylation program is essential for maintaining the mitotic fidelity in proliferating mantle cell lymphoma cellsWalter Hanel, Pushpa Lata, Youssef Youssef, et al.
Blood Advances|June 16, 2023
PRMT5 inhibition drives therapeutic vulnerability to combination treatment with BCL-2 inhibition in mantle cell lymphomaFiona Brown-Burke, Inah Hwang, Shelby Sloan, et al.
Pageof 6